Elpi Lip

Long-acting hypolipemiant Indicated to treat hypercholesterolemia (Type Lia) and endogenous hypertriglyceridemia, isolated (type IV) or associated (type IIb and III).

Therapeutic Area
Hypolipemiant

Active Ingredient
Bezafibrate

Line
Cardiometabolism

Pharmaceutical Form
400 mg extended-release tablets x 30

Download Leaflet Descargar